This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB04478/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04478/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04478/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04478/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04478
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04478 n13:DB04478
dcterms:title
Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine
adms:identifier
n8:132302 n9:46507845 n10:DB04478 n11:572
n3:IUPAC-Name
n4:271B5DA1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5DA7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5DA6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5DA3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5DA4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5DA5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5D9F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5D9D-363D-11E5-9242-09173F13E4C5 n4:271B5DA0-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5D9E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5DAD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5DAE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5DA8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5DA9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5DAB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5DAA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5DAC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5DB3-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5DB5-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5DB6-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5DB2-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5DB1-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5DB4-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5DA2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5DAF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5DB0-363D-11E5-9242-09173F13E4C5